date:Jul 25, 2013
ompared to a 10-point improvement for the placebo group, according to results published in the Journal of the National Cancer Institute.
That's more than enough change to be noticeable in daily life, according to the scale.
Of the 364 people enrolled at the start of the study, 80 dropped out before the eight-week mark. Although that's a high number, dropout rates were similar in each group - so the results shouldn't be affected, Barton said.
Side effects such as nausea, vomiting and anxiety w